PATENT CLAIM ANALYSIS

Application Number: 15757266
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "557000"]

Abstract:
Certain embodiments are directed to composition and methods related to 23 hydroxy ursolic acid and it use in attenuating the effects to monocyte hypersensitivity or hyper-reactivity

Claim (Index 3):
The method of  claim 1 , wherein the subject is administered about 1 to 500 mg of 23 hydroxy ursolic acid or salt thereof per kilogram of body weight.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 90.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15308427', '15318876', '14650685', '10567543', '13886053']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6673126646135327
- 35 USC 102 Novelty (BERT): 0.4986564411986763
- Combined Prediction Score: 0.650447042272047
- Mean Citation Score: 191.563408
- Max Citation Score: 203.46341
- Similarity Product: 144.6919712745619

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test